The 16th International Conference on Thalassaemia and Other Haemoglobinopathies & 18th TIF Conference for Patients and Parents will take place on 3-5 November 2023, at the Grand Hyatt Hotel, Kuala Lumpur, Malaysia.  

The event is expected to attract more than 2,000 participants from over 62 countries, in the field of Thalassaemia and Haemoglobinopathies, ranging from patients and patient/parent organisations, healthcare professionals/ medical specialists, academics/ researchers, policy-makers at national, regional and international level, and industry representatives.

As one of the sponsors of the TIF 2023, Hybribio is thrilled to announce its participation in prestigious conference. With years of dedication to developing a diagnostic solution for thalassemia, Hybribio has amassed a wealth of experience in diagnosis and prevention. Moreover, we’re honored to have our R&D Director, Dr. Mengyu Liu, deliver an enlightening speech on thalassemia screening and prevention at the satellite symposium. Don’t miss this opportunity to gain valuable knowledge from a leading expert in the field! Join us at TIF 2023 for an event that promises to be both informative and inspiring.

Topic: The optimization of prenatal and newborn screening for thalassemia in China.

Date: 4th November 2023

Time: 18:15-19:15

Venue: Grand Ballroom, Grand Hyatt Kuala Lumpur, Malaysia

Looking forward to meeting you in TIF 2023. Your presence will make the conference more meaningful!